Zhuhai Qisitech Responds to 2Firsts: Emergency Plan Activated, Suspends Production of Affected Products

Industry Insight by 2FIRSTS

Oct.17.2024

Zhuhai Qisitech Responds to 2Firsts: Emergency Plan Activated, Suspends Production of Affected Products

Zhuhai Qisitech responds to being on FDA "red list," taking swift actions to address concerns.

On October 16th, 2Firsts reported that a manufacturing product of Zhuhai Qisitech (referred to as "Zhuhai Qisi") was included in the "red list" incident. (Click here to read the article).

In response to the incident, Zhuhai Qisi issued a statement today (October 17th), addressing two key points. The specifics of their response are as follows:

1. The product in question does not belong to our company.
2. The management team of Zhuhai Qisi has attached great importance to this matter, conducting a thorough analysis and investigation in a timely manner while actively implementing response measures. As a global aerosol contract manufacturing company, Zhuhai Qisi has always placed product quality and compliance at a high priority. In response to the recent FDA announcement, the company has swiftly initiated an emergency plan, demonstrating a firm attitude and efficient actions in addressing the issue.

Currently, Zhuhai Qisi has decisively stopped production of the products involved, actively contacted customers and brands, and jointly carried out an investigation to cope with this crisis, making every effort to minimize the adverse impact on the market. At the same time, Zhuhai Qisi is actively communicating with the FDA. We also hope that in the future, the FDA will conduct more comprehensive evaluations and considerations for every product from China.

In conclusion, we will continue to enhance communication and cooperation with customers and regulatory authorities, providing reliable and compliant products to the market and consumers with a high sense of responsibility.

(Above is the original response from Zhuhai Qisi)

2Firsts will continue to follow the development of the event and provide updates on relevant news.

Also Read:

[1] A Product of Geekvape's Subsidiary Zhuhai Qisitech Listed in FDA Import Alert, Facing Risk of Automatic Detention

[2] FDA Updates Import Alert Including Red List of E-Cigarettes

[3] E-Cigarette Industry Shifts: "Heaven Gifts + Geekvape" Surpass Smoore as Market Leader

#E-liquids #Asia #Market #China

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways

2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.

Oct.13

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

According to The Guardian, the British Museum has ended its 15-year sponsorship with Japan Tobacco International after government inquiries into whether the deal breached WHO tobacco-control rules. Critics had long opposed the partnership, while the museum said sponsorship remains essential for its financial stability and public access.

Nov.20

1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly

Over 1,200 UK health leaders urged Parliament to pass the Tobacco and Vapes Bill quickly, calling it vital to protect future generations. The bill would ban tobacco sales to anyone born after Jan 1, 2009, and restrict vape packaging and flavours. Health groups warned delays risk undermining “gamechanging” public health reforms.

Oct.27 by 2FIRSTS.ai

Bremen Sees Active Illicit Trade in E-Cigarettes and Nicotine Pouches; Regulators Say ‘Nearly Every Inspection Finds Violations’

Bremen’s state government warns of increasingly active illicit trade in e-cigarettes, snus, and nicotine pouches. Enforcement reports “violations in nearly every inspection,” with some disposable vapes exceeding Germany’s 2 ml e-liquid cap. Since 2024, authorities have recorded 54 violations in 255 checks, concentrated around the central station district and city center.